<DOC>
	<DOCNO>NCT00466154</DOCNO>
	<brief_summary>Aspirin resistance persistent platelet activation , demonstrate platelet function test ( 1 ) . The hypothesis : LDL lower statin patient aspirin resistance improve effect aspirin due potential decreasing cholesterol content platelet membrane . Patients method : Forty hypercholesterolemic patient aspirin resistance 5 day treatment aspirin high LDL triglyceride &lt; 300 mg/dL , enrol . Ten healthy volunteer control group .</brief_summary>
	<brief_title>The Effect Serum LDL Lowering Aspirin Resistance</brief_title>
	<detailed_description>The patient treat aspirin load dose 500mg 100 mg/day 4 day . For patient entrolled regular working hour , platelet aggregation test cholesterol content platelet membrane do baseline . Blood test lipid , liver ( ALT , AST , GGT , Alkaline phosphatase bilirubin ) renal function test ( blood urea nitrogen creatinine ) , complete blood count , general urine test serum homocysteine do second day . On fifth day optical platelet aggregation test , cholesterol content platelet membrane , platelet function PFA-100 system soluble p-selectin plasma do If patient aspirin resistance ( platelet aggregation 20 % epinephrine 70 % ADP ) , LDL lower plasma 20 patient hypolipidemic drug ( statin alone combined ezetimibe ) . Other 20 patient continue treat aspirin alone . One month later , blood test lipid , liver ( ALT , AST , GGT , Alkaline phosphatase bilirubin ) renal function test ( blood urea nitrogen creatinine ) , complete blood count , general urine test serum homocysteine do second time platelet activity test patient . Platelet separation : For platelet study , venous blood ( 30 ml ) collect siliconized syrinx acid citrate dextrose solution ( 1.4 % citric acid , 2.5 % sodium citrate , 2 % dextrose ) ratio 9:1 ( v : v ) wash platelet ( WP ) preparation.WP prepared centrifugation 240g 20 min . The platelet bellet wash twice 5 mmol Hepes buffer , pH 7.4 ( 140 mmol NaCl , 2 mmol KCL , 1 mmol MgCl2 , 5 mmol Hepes , 12 mmol NaHCO3 5.5 mmol glucose ) . For preparation WP suspension , 15 uL acetic acid ( 1mmol ) add 1 ml platelet suspension throughout WP preparation order ensure acidic condition require platelet resuspension . This procedure reduce medium pH 6.5 influence aggregation response WP . Platelet aggregation : Collagen ( Nycomed , germany ) use aggregate agent concentration 4 ug/ml ( concentration cause 60 % aggregation amplitude WP ) . Platelet aggregation perfomed 37ºC aggregometer use hepes reference system . Results express extent maximal aggregation ( % maximal amplitude ) also slope aggregation curve ( cm/min ) . Cholesterol content platelet membrane : Platelets wash three time Hepes buffer , sonicated twice 20 second 80 watt . Platelet lipid extract hexane : isopropanolol ( 3:2 , v : v ) . The cholesterol content measure dried hexane phase method Chiamori et al ( 12 ) . Platelet protein determine use method Lowry ( 13 ) .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>1 . Hypercholesterolemic lowmoderate risk patient without hypolipidemic drug least one month . 2 . Age ≥18 year stable AHA step 1 diet . 3 . For primary prevention , LDL &gt; 130 mg/dL secondary prevention LDL &gt; 70 &lt; 100mg/dL . . 4 . CPK , ALT AST &lt; 1.5 x upper limit normal baseline . 1 . Women currently receive cyclical hormone . 2 . Treatment hypolipidemic drug last month . 3 . Oral corticosteroid , NSAID , COX1 inhibitor antiplatelet drug . 4 . Women childbearing potential unless safe contraception . 5 . Psychiatric disease defect judgement . 6 . Severe renal hepatic diease . 7 . Uncontrolled hypo hyperthyroidism . 8 . Contraindication ezetimibe statin treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Aspirin resistance</keyword>
	<keyword>Platelet activation</keyword>
	<keyword>Hypercholesterolemia</keyword>
</DOC>